Peoria, IL, United States of America

David P Labeda


Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 244(Granted Patents)


Location History:

  • Monsey, NY (US) (1983 - 1986)
  • Peoria, IL (US) (1985 - 1995)

Company Filing History:


Years Active: 1983-1995

Loading Chart...
19 patents (USPTO):Explore Patents

Title: David P. Labeda: A Pioneer in Antibiotic Innovation

Introduction

David P. Labeda is a distinguished inventor based in Peoria, Illinois, known for his significant contributions to the field of antibiotics. With a remarkable portfolio of 19 patents, Labeda's innovations are centered around antibacterial agents derived from unique microorganisms, showcasing his commitment to advancing medical science.

Latest Patents

Among his latest patents, Labeda has developed antibiotic LL-D37187.alpha., which is derived from the microorganism Streptomyces. This particular invention is noteworthy for its potential as an antibacterial agent. In addition, he has disclosed novel antibacterial agents designated LL-E10985.alpha., LL-E19085.beta., LL-E19085.gamma., LL-E19085.zeta., and LL-E19085.eta. These agents are produced through aerobic fermentation from a new subspecies of Micromonospora citrea, specifically NRRL 18351, along with its mutants. This work highlights Labeda's innovation in isolating and purifying potent antibacterial compounds.

Career Highlights

David P. Labeda is currently associated with the American Cyanamid Company, where he continues to push the boundaries of antibiotic research and development. His body of work not only reflects his expertise but also his dedication to improving health outcomes through innovative antibiotic solutions.

Collaborations

Throughout his career, Labeda has collaborated with esteemed colleagues, including Donald B. Borders and Joseph J. Goodman. These partnerships have played a crucial role in advancing his research and expanding the impact of their collective work in the field of antibiotics.

Conclusion

David P. Labeda stands out as a significant figure in the realm of antibiotic innovation. With numerous patents to his name and groundbreaking research involving unique microorganisms, he is at the forefront of developing new antibacterial agents that promise to enhance medical treatment options. His career is an inspiring example of how dedication to research and collaboration can lead to impactful innovations in health care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…